SVB Leerink analyst Mani Foroohar maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and lowers the price target from $66 to $64.
Reported Late Monday, PennantPark Floating Rate Capital Announces Pricing Of $47.6M Public Offering Of 4.25M Share Of Common Stock At A Price Of $11.20/Share
PennantPark Floating Rate Capital Ltd. (NYSE:PFLT) (TASE: PFLT), a business development company (the "Company"), today announced that it has entered into an agreement to sell 4,250,000 shares of common stock
